MY ACCOUNT | NEWSLETTER |

Zealthy Launches Enhanced Weight-Loss Care Platform With Integrated Zepbound Access and Insurance Support

Industry development with potential relevance for veterinary professionals, companion animal care, and animal health stakeholders.


Rising veterinary costs and growing owner expectations are reshaping the economics of companion animal care.

According to the announcement, Zealthy Launches Enhanced Weight-Loss Care Platform With Integrated Zepbound Access and Insurance Support. The development is relevant because it reflects how animal health companies, service providers, and technology platforms are responding to changing expectations in veterinary care.

What Was Announced

New York, NY, June 23, 2026 (GLOBE NEWSWIRE) -- Zealthy announced today the launch of its enhanced virtual weight-loss care platform, designed to simplify access to provider-guided obesity treatment through integrated telehealth services, insurance coordination, prescription management, and ongoing patient support. The platform enables eligible patients to complete an online health assessment, connect with a licensed healthcare provider, and receive treatment recommendations through a fully digital care experience.

Zepbound is FDA-approved to help eligible adults lose excess body weight and maintain weight reduction when used with a reduced-calorie diet and increased physical activity. It is also approved to treat moderate-to-severe obstructive sleep apnea in adults with obesity.

Why This Matters for Veterinary Professionals

For veterinary teams, broader insurance adoption can influence treatment acceptance, client communication, and access to advanced diagnostics or specialty care.

Financial limitations remain one of the most common barriers to advanced veterinary care. Greater insurance penetration may help some pet owners pursue diagnostics, surgery, chronic disease treatment, and preventive care with less immediate pressure from out-of-pocket costs.

Industry Perspective

The expansion of pet insurance reflects a wider shift in which financial tools are becoming part of the veterinary care conversation.

While individual announcements should be interpreted in the context of their source, they can help veterinary professionals monitor where investment, innovation, and market attention are moving across the animal health sector.

Original announcement: Zealthy — https://www.globenewswire.com/news-release/2026/06/23/3316364/0/en/zealthy-launches-enhanced-weight-loss-care-platform-with-integrated-zepbound-access-and-insurance-support.html

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Idiopathic Hypercalcemia in Cats

Like0
Dislike0

Unified Information Devices, Inc.

Like0
Dislike0

Effectiveness and long-term safety of repeated oral administrations of molidustat in the management of anemia associated with chronic kidney disease in cats.

Like0
Dislike0

The polysaccharide Pullulan improves the initial steps of allergen-specific immunotherapy in dogs.

Like0
Dislike0

Real-world use of and clinical outcomes with dacomitinib as first-line therapy in Asian patients with EGFR mutation-positive locally advanced or metastatic non-small cell lung cancer: Final analysis of the ARIA study.

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top